Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...

Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...

A Garda superintendent told a trial on Wednesday that he and a colleague seized summons sheets, mobile phones, computer equipment, and documents when they raided the office of a Limerick Garda ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

Long Harbour adds to £1.2B single-family home target; Aviva loans for Petty France; LondonMetric places £500M bond; Whitbread ...

The Court upheld the refusal to discharge the accused, citing material suggesting grave suspicion of involvement in a conspiracy. It held that the allegations warranted full trial ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.

Initial data from a phase 2 (NCT05256290) clinical trial show that silevertinib yields robust antitumor activity and ...

Much of the $3 trln splurge on server farms for artificial intelligence is coming from Big Tech firms. But developers are ...

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic ...